Screener
Kymera Therapeutics KYMR Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Kymera Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Kymera Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333849
FAQ
- What is Kymera Therapeutics's price / sales?
- Kymera Therapeutics (KYMR) reported price / sales of 89.8× in Q2 2026.
- How has Kymera Therapeutics's price / sales changed year-over-year?
- Kymera Therapeutics's price / sales increased by 30.8% year-over-year, from 68.7× to 89.8×.
- What is the long-term trend for Kymera Therapeutics's price / sales?
- Over 5 years (2020 to 2025), Kymera Therapeutics's price / sales has grown at a 14.3% compound annual growth rate (CAGR), from 81.3× to 158.8×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about Kymera Therapeutics's price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude